EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A single cysteine residue in vimentin regulates long non-coding RNA XIST to suppress epithelial–mesenchymal transition and stemness in breast cancer

Saima Usman iD, William Andrew Yeudall iD, Muy-Teck Teh iD, Fatemah Ghloum iD, Hemanth Tummala iD, Ahmad Waseem iD

eLife · 2025

DOI: 10.7554/elife.104191 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Saima Usman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Oral Immunobiology and Regenerative Medicine, Institute of Dentistry, Barts and The London School of Medicine and Dentistry, Queen Mary Un…. Hauptthemen laut MEDLINE: Vimentin, Epithelial-Mesenchymal Transition, RNA, Long Noncoding, Breast Neoplasms. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDCR NIH HHS, Higher Education Commission, Pakistan, National Institute of Dental and Craniofacial Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vimentin is a type III intermediate filament (IF) protein that is induced in a large number of solid tumours. A single cysteine at position 328 in vimentin plays a crucial role in assembly, organisation, and stability of IFs. However, its exact function during epithelial–mesenchymal transition (EMT) and cancer progression has not been investigated. To investigate this, we have transduced wildtype (WT) and C328S vimentin separately in MCF-7 cells that lack endogenous vimentin. The expression of C328-VIM impacted vimentin–actin interactions and induced EMT-like features that include enhanced cell proliferation, migration, and invasion accompanied by reduced cell adhesion when compared to the wildtype cells. Functional transcriptomic studies confirmed the upregulation of EMT and mesenchymal markers, downregulation of epithelial markers, as well as acquisition of signatures associated with cancer stemness ( CD56, POU5F1, PROCR, and CD49f ), thus transforming MCF-7 cells from oestrogen-positive to triple-reduced ( ESR1, PGR, and HER2 ) status. We also observed a stark increase in the expression of long non-coding RNA, XIST, in MCF-7 cells expressing C328-VIM. Targeting the mutant vimentin or XIST by RNA interference partially reversed the phenotypes in C328-VIM-expressing MCF-7 cells. Furthermore, the introduction of C328-VIM cells into nude mice promoted tumour growth by increasing cancer stemness in an oestrogen-independent manner. Altogether, our studies provide insight into how cysteine 328 in vimentin dictates mechano-transduction signals to remodel actin cytoskeleton and protect against EMT and cancer growth via modulating lncRNA XIST . Therefore, targeting vimentin and/or XIST via RNA interference should be a promising therapeutic strategy for breast cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VimentinEpithelial-Mesenchymal TransitionRNA, Long NoncodingBreast NeoplasmsCysteineNeoplastic Stem CellsHumansAnimalsFemaleMCF-7 CellsMiceGene Expression Regulation, NeoplasticCell Proliferation

Stichwörter der Autor:innen

RNA interferenceRNA-Seqbreast cancer signaturecancer biologycancer stem cellscell biologyhumanintermediate filamentsmetastasismouseviruses

Substanzen

VimentinRNA, Long NoncodingXIST non-coding RNACysteineVIM protein, human

Autor:innen und Institutionen

  • Centre for Oral Immunobiology and Regenerative Medicine, Institute of Dentistry, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
  • Department of Oral Biology and Diagnostic Sciences, The Dental College of Georgia, Augusta University, Augusta, United States.
  • Georgia Cancer Center, Augusta University, Augusta, United States.
  • Centre for Genomics and Child Health, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.

ORCID-Profile: Saima Usman, William Andrew Yeudall, Muy-Teck Teh, Fatemah Ghloum, Hemanth Tummala, Ahmad Waseem

Förderung

  • NIDCR NIH HHS
  • Higher Education Commission, Pakistan
  • National Institute of Dental and Craniofacial Research

Zitieren

APA

Usman, S., Yeudall, W. A., Teh, M. T., Ghloum, F., Tummala, H., & Waseem, A. (2025). A single cysteine residue in vimentin regulates long non-coding RNA XIST to suppress epithelial–mesenchymal transition and stemness in breast cancer. eLife. https://doi.org/10.7554/elife.104191

Vancouver

Usman S, Yeudall WA, Teh MT, Ghloum F, Tummala H, Waseem A. A single cysteine residue in vimentin regulates long non-coding RNA XIST to suppress epithelial–mesenchymal transition and stemness in breast cancer. eLife. 2025. doi:10.7554/elife.104191

BibTeX
@article{Usman2025,
  author = {Usman, Saima and Yeudall, William Andrew and Teh, Muy-Teck and Ghloum, Fatemah and Tummala, Hemanth and Waseem, Ahmad},
  title = {A single cysteine residue in vimentin regulates long non-coding RNA XIST to suppress epithelial–mesenchymal transition and stemness in breast cancer},
  journal = {eLife},
  year = {2025},
  doi = {10.7554/elife.104191}
}
Kostenlos starten →